ClinicalTrials.gg

Drug

Fremanezumab clinical trials

Also written TEV-48125 and Ajovy.

studies test it
29
open now
2
in phase 3
14
first study started
2013

Keep track of what changes. Save the fremanezumab studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

27 studies that test it; most in 2017 (8); 2 more planned to start later

Studies that test fremanezumab, by start year
YearStudies
20131
20142
20163
20178
20192
20205
20213
20222
20241

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
8
Phase 3
14
Phase 4
6
No phase
1

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 23 · Other 6

Teva Branded Pharmaceutical Products R&D, Inc. (17) · Otsuka Pharmaceutical Co., Ltd. (3) · Brigham and Women's Hospital (1) · Teva Branded Pharmaceutical Products R&D LLC (1) · David True (1) · M.D. Anderson Cancer Center (1) · Insel Gruppe AG, University Hospital Bern (1) · Beth Israel Deaconess Medical Center (1)

Often tested with

Tested in the same studies.

Prednisone (1) · Eptinezumab (1) · Erenumab (1) · Onabotulinum toxin A (1) · Galcanezumab (1)

Studies

Open first, then newest update. How each study uses fremanezumab is read from its arms, and is right about nine times in ten.

Testing it · 29

See all 29 studies that test fremanezumab →

Codes

What other systems call fremanezumab · ClinicalTrials.gg INT000387

  • UNII (FDA) PF8K38CG54FREMANEZUMABConfirmed FDA, Wikidata
  • RxNorm 2056691Confirmed FDA, Wikidata
  • Wikidata Q39048381fremanezumabConfirmed FDA, Wikidata
  • NCI Thesaurus C174842FremanezumabOne source FDA
  • DrugBank DB14041One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.